Cervical cancer remains the second most common cancer in women worldwide and the
most frequent in developing countries. Pre-neoplasic cervical lesions represent an …

PURPOSE: Global data on age-specific prevalence of human papillomavirus (HPV) infection
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …

This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to
Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous …

An inverse relationship between age and human papillomavirus (HPV) prevalence has
been reported in many developed countries, but information on this relationship is scarce in …

Human papillomavirus (HPV) DNA testing was recently approved by the Food and Drug
Administration for use as an adjunct to cytology for cervical cancer screening. To help …

We present a transmission dynamic model that can assess the epidemiologic consequences
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent …

Genital Chlamydia trachomatis (CT) infections have been identified as a major health
problem concern. CT is associated with adverse effect on women reproduction and also …

Background Histopathology is a cornerstone in the diagnosis of cervical cancer but the
prognostic value is controversial. Methods Women under active follow-up for histologically …

Persistent high-risk human papillomavirus (HR-HPV) infections play a major role in the
development of invasive cervical cancer (CC), and screening for such infections is in many …

Background Cervical cancer is a major public health problem in Latin America and the
Caribbean (LA&C), showing some of the highest incidence and mortality rates worldwide …